cytarabine and fi-700
cytarabine has been researched along with fi-700 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Akinaga, S; Arai, H; Ishii, K; Kiyoi, H; Kosugi, H; Naoe, T; Ozeki, K; Shimizu, M; Shiotsu, Y; Umehara, H; Yamaji, S | 1 |
Other Studies
1 other study(ies) available for cytarabine and fi-700
| Article | Year |
|---|---|
A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutations.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Blotting, Western; Cell Proliferation; Cytarabine; Drug Therapy, Combination; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Humans; Leukemia; Mice; Mice, Inbred C3H; Mice, SCID; Mutation; Pyridines; Pyrimidines; Signal Transduction; STAT5 Transcription Factor; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2007 |